 NEW YORK, March 05, 2021 GLOBE NEWSWIRE -- Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of Immunovant, Inc. fka Health Sciences Acquisitions Corporation NASDAQ: IMVT, HSACU, HSAC, HSACW between October 2, 2019 and February 1, 2021, inclusive the Class Period. The lawsuit seeks to recover damages for Immunovant, Inc. investors under the federal securities laws. 